← All trials
NCT04942405
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 21, 2021
- Primary completion
- Jan 21, 2022
- Completion date
- Mar 31, 2023
- First posted
- Jun 28, 2021
- Last posted
- Oct 19, 2021
- Enrollment
- 40800
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of TurkeyLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.